Johnson & Johnson (NYSE:JNJ) recently announced the election of Daniel Pinto, a seasoned executive with extensive experience, to its Board of Directors, potentially reinforcing its strategic oversight ...

US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a ...

Johnson & Johnson (NYSE: JNJ) announced today that it elected JPMorganChase President Daniel Pinto to its board of directors.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Avanza Fonder AB reduced its stake in Johnson & Johnson by 11.9% in Q1, selling 30,668 shares worth around $35.44 million.

Johnson & Johnson has elected JPMorganChase's President Daniel Pinto to its Board of Directors.Pinto is a prominent business ...

Johnson & Johnson is making a massive bet on American soil. Over the next four years, the healthcare giant plans to invest ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Johnson & Johnson MedTech has introduced the ETHICON 4000 Stapler, a surgical device for managing tissue complexities.

Johnson & Johnson (NYSE: JNJ) announced today that Daniel Pinto, President, JPMorganChase, has been elected to its Board of ...

Ethicon 4000 features proprietary 3D staple technology, a redesigned end effector and streamlined reload options. The company ...

Early Phase I results for JNJ-79635322 demonstrated an 86.1% overall response rate in heavily pretreated multiple myeloma ...